期刊文献+

接种HBV疫苗的HIV感染者血清抗-HBs 5年阳性率及影响因素 被引量:3

Seroprevalence and the influencing factors of anti-HBs antibody after five-year hepatitis B vaccination in HIV-infected persons
原文传递
导出
摘要 目的分析HIV感染者接种乙型肝炎(简称乙肝)疫苗后5年血清乙肝表面抗体(抗-HBs)阳性率及其影响因素,为优化HIV感染者乙肝疫苗免疫策略提供科学依据。方法以云南省德宏州HBV五项检测均为阴性并完成5年随访的761例HIV感染者为研究对象。在首针接种后5年时检测抗-HBs,分析HIV感染者乙肝疫苗接种后的长期免疫效果及其影响因素。结果761例HIV感染者中359例(47.2%)完成乙肝疫苗接种。5年抗体阳性率为12.2%(93/761),接种组为21.2%(76/359),未接种组为4.2%(17/402);多因素分析结果显示,接种乙肝疫苗、女性感染者5年血清抗-HBs阳性率较高,较大年龄、病毒载量≥200 copies/mL则较低。进一步对接种疫苗的359例HIV感染者进行多因素分析,结果显示,女性感染者(OR=2.38,95%CI:1.29~4.39)在接种乙肝疫苗5年后血清抗-HBs阳性率水平显著高于男性感染者;而较大年龄(40~49岁:OR=0.38,95%CI:0.17~0.85;≥50岁:OR=0.21,95%CI:0.07~0.65)的感染者则显著低于15~29岁的感染者。结论HIV感染者注射乙肝疫苗5年后抗-HBs水平仍显著高于未接种者,但男性、大龄及病毒载量较高者接种后免疫持久性较差,应予以关注。 Objective To investigate the prevalence and associated factors of serum hepatitis B surface antibody(anti-HBs)and 5 years after completion of first hepatitis B vaccination among HIV-infected persons.Methods A total of 761 HIV-infected persons in Dehong prefecture of Yunnan province who were both negative for hepatitis B and completed 5-year follow-up were included.Anti-HBs was measured 5 years after the first vaccination.Results Hepatitis B vaccination was completed in 359(47.2%)of 761 HIV-infected patients.The 5-year prevalence of anti-HBs was 12.2%(93/761),with a prevalence of 21.2%(76/359)and 4.2%(17/402)in the vaccinated and unvaccinated group respectively.Multivariate analysis showed that serum anti-HBs among all participants was higher in women infected with hepatitis B vaccine for 5 years,but lower in people with older age and viral load≥200 copies/mL.Multivariate analysis of 359 HIVinfected persons who were vaccinated,the female(OR=2.38,95%CI:1.29-4.39)were associated with increased serum anti-HBs prevalence.The older age(40~49 years:OR=0.38,95%CI:0.17-0.85;≥50 years:OR=0.21,95%CI:0.07-0.65)were associated with reduced serum anti-HBs prevalence.Conclusions Seroprevalence of anti-HBs antibody among HIV-infected persons after 5 years of HBV vaccination is still significantly higher than those unvaccinated.However,the sustainability of anti-HBs antibody is relatively lower among vaccinated HIVinfected persons who are male and older with higher viral load,which calls for particular attentions.
作者 唐仁海 李畅 王继宝 叶润华 杨锦 段星 王译葵 高洁 项丽芬 杨跃诚 丁盈盈 何纳 段松 TANG Renhai;LI Chang;WANG Jibao;YE Runhua;YANG Jin;DUAN Xing;WANG Yikui;GAO Jie;XIANG Lifen;YANG Yuecheng;DING Yingying;HE Na;DUAN Song(Dehong Prefecture Center for Disease Control and Prevention,AIDS STD Prevention and Control Division,Mangshi 678400,China;Department of Epidemiology,School of Public Health,Fudan University,Shanghai 200032)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2022年第6期652-657,共6页 Chinese Journal of Aids & STD
基金 国家自然科学基金项目(81773485)。
关键词 艾滋病病毒感染者 乙型肝炎疫苗 乙型肝炎病毒表面抗体阳性率 接种 HIV infected persons Hepatitis B vaccine Anti-HBs prevalence vaccination
  • 相关文献

参考文献2

二级参考文献19

  • 1Saibal Das,Kirubakaran Ramakrishnan,Sapan Kumar Behera,Mahalakshmi Ganesapandian,Alphienes Stanley Xavier,Sandhiya Selvarajan.Hepatitis B Vaccine and Immunoglobulin: Key Concepts[J].Journal of Clinical and Translational Hepatology,2019,7(2):165-171. 被引量:4
  • 2庄贵华,颜虹,王学良.乙型肝炎疫苗接种无应答原因与机制[J].中华肝脏病杂志,2006,14(2):157-160. 被引量:27
  • 3王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
  • 4Thio CL, Seaberg EC, Skolasky R Jr, et al. Muhicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Muhicenter AIDS Cohort Study(MACS)[J]. Lancet,2002, 360:1921-1926. 被引量:1
  • 5Konopnicki D, Mocroft A, de Wit S, etal. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiret- roviral therapy and increased mortality in the EuroSIDA Cohort [J]. AIDS,2005, 19:593-601. 被引量:1
  • 6Pasricha N, Datta U, Chawla Y, et al. Immune responses in pa- tients with HIV infection after vaccination with recombinant hep- atitis B virus vaccine[J]. BMC Infect Dis, 2006, Mar 30(6) : 65. 被引量:1
  • 7Shire NJ, Sherman KE. Management of hepatitis B virus in HIV- positive patients[J]. Minerva Gastroenterol Dietol, 2006, 52 : 67- 87. 被引量:1
  • 8Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive im- munization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II:immuniza- tionof adults[J]. MMWR Recomm Rep, 2006, 55(RR-16): 1- 33. 被引量:1
  • 9Launay O, van der Vliet D, Rosenberg AR, etal. Safety and m- munogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 ..a randomized controlled trial[J]. JAMA, 2011, 305 (14) : 1432-1440. 被引量:1
  • 10Kim HN, Harrington RD, Van Rompaey SE, et al. Independent clinical predictors of impaired response to Hepatitis B vaccination in HIV-infected persons[J]. Int J STD AIDS, 2008, 19(9):600- 604. 被引量:1

共引文献8

同被引文献36

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部